Is Morningstar worth it?

At $249 a year you are buying the judgement of people — analyst reports, fair value estimates and moat ratings written by people rather than generated. Whether that is worth it comes down to one question you can answer during the trial.

The short answer

Morningstar Investor costs $249 a year and is worth it if you will actually read the analyst reports. What you are buying is the judgement of people — written analysis, fair value estimates and moat ratings produced by people rather than an algorithm. That is rare, and almost nothing else at this price offers it. If you want screening and charting, you can get better for less elsewhere.

What it costs

Note that Morningstar's four newsletters — FundInvestor, StockInvestor, DividendInvestor and ETFInvestor — are a separate subscription at around $170 a year. They are not included.

The tier structure changed in April 2025, when Morningstar Investor replaced the older Premium plan and consolidated everything into one product. Older reviews describing multiple tiers are out of date.

What you are actually paying for

Three things, and it is worth being clear which of them matters to you.

Portfolio X-Ray is the fourth thing people rate highly. It looks through your holdings and shows what you actually own underneath — useful when three different funds all turn out to hold the same handful of companies, and there is now an AI research assistant and direct brokerage integration.

Where it is weaker

So is it worth it?

Yes, if you will read the research. That is the whole test. Morningstar's cost sits almost entirely in the written analysis, so the question is not whether the product is good — it is — but whether you are the sort of investor who reads a twelve-page report on a company before buying it. If you are, $249 is a fair price for something nothing else at this level offers.

No, if what you want is the number. Plenty of people subscribe, glance at the star rating, and act on that. If that is you, you are paying $249 a year for a one-to-five score, and you can get a valuation and a margin of safety for less elsewhere.

How to find out which you are, before paying. There is a seven-day free trial and it does need a card. Use it properly: pick three companies you already own and read the full analyst report on each, start to finish. If you finish all three and have learned something that changes how you think about a holding, subscribe. If you find yourself scrolling to the star rating on the second one, you have your answer and it cost you nothing.

Two practical notes if you do subscribe. Take the annual plan — monthly billing is $34.95, which is $419.40 a year against $249, and there is no benefit for the extra $170. And look for the new-subscriber discount, which commonly brings the first year to around $199; it applies to annual plans only and does not extend an existing subscription.

If it is the wrong fit, here is the alternative we built

These two products overlap more than most. Both publish an intrinsic value from discounted cash flow. Both score economic moats. The difference is how the coverage is produced, and what that means for the company you happen to be researching.

Morningstar's strength is depth on the companies its analysts cover. On a large, widely followed US company, a written report by a named analyst is hard to beat.

Oak Growth's strength is that coverage never runs out. Every one of the 1,000+ companies across eight markets — the FTSE 100 and 250, the US, Europe, Japan, Hong Kong, Australia, Germany and France — gets an intrinsic value, a margin of safety and a moat score. Analyst-written research is necessarily sized to the number of analysts writing it, and that means UK mid-caps, European industrials and Asian listings get thin treatment or none. If the company you are looking at falls outside a research desk's priority list, depth on other companies does not help you.

Oak Growth also publishes entry-timing signals — RSI, moving averages, support and resistance, golden and death crosses — alongside the valuation. Morningstar has no technical layer at all. Knowing a company is undervalued and knowing whether it is still falling are different questions, and Oak Growth answers both on the same card.

On price: Morningstar Investor is $249 billed annually, roughly £190, and you commit for the year. Oak Growth is £18 a month with no annual lock-in, so the decision to keep paying is one you make twelve times rather than once. Broadly comparable money; different commitment.

The honest summary: if you hold a concentrated portfolio of large US companies and will read full analyst reports on them, Morningstar's depth earns its price. If you are screening across markets for candidates — particularly outside the US — analyst coverage will not reach most of what you are looking at, and a valuation on every company in the universe is worth more than a longer document about a few of them.

Side by side

Common questions

Also see: Oak Growth vs Morningstar → · Is Simply Wall St worth it? → · What is an economic moat? →